These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of beta-blocking or alpha.beta-blocking agents upon circadian cardiovascular rhythm of healthy male subjects. Otsuka K; Watanabe H; Cornelissen G; Halberg E; Halberg F Prog Clin Biol Res; 1990; 341A():297-304. PubMed ID: 1699233 [No Abstract] [Full Text] [Related]
8. Evaluation of various adrenergic blocking agents in isolated rabbit and turtle hearts. Meester WD; Hardman HF; Barboriak JJ J Pharmacol Exp Ther; 1965 Oct; 150(1):34-40. PubMed ID: 4379105 [No Abstract] [Full Text] [Related]
9. [Effects of the blocking of the beta adrenergic receptors on hemodynamic reactions induced by changes of posture]. Granata L; Pasquè A; Caraffa Braga E; Data PG Boll Soc Ital Biol Sper; 1968 Oct; 44(20):1653-6. PubMed ID: 5720239 [No Abstract] [Full Text] [Related]
10. [Hemodynamic effects of a new beta-adrenergic blocking agent. Study of normal subjects in various cardiocirculatory functional conditions]. Starcich R; Barbaresi F; Bacuzzi E; Valentino RV Minerva Cardioangiol; 1966 Nov; 14(11):650-7. PubMed ID: 5999111 [No Abstract] [Full Text] [Related]
11. [The effect of sympatholytin on the development of the hemodynamic effects of thyroid hormones]. Ester KM; Kandror VI Biull Eksp Biol Med; 1967 Jun; 63(6):30-3. PubMed ID: 5622606 [No Abstract] [Full Text] [Related]
12. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A. Wiśniewska RJ Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628 [TBL] [Abstract][Full Text] [Related]
13. [Differentiation of adrenergic receptors and their variable importance in drug therapy]. Hapke HJ Dtsch Tierarztl Wochenschr (1946); 1969 Nov; 76(22):617-21. PubMed ID: 4922890 [No Abstract] [Full Text] [Related]
14. [Effect of treatment with dexamethasone on cardiovascular responses of adrenergic agents]. Gorzalczany SB; Bramuglia GF; Tchercansky DM; Taira CA Acta Physiol Pharmacol Ther Latinoam; 1997; 47(1):1-8. PubMed ID: 9410222 [TBL] [Abstract][Full Text] [Related]
15. Effect of sympatholytic agents on cardiovascular, respiratory and glottal changes during the apnoeic reflex of nasal origin. Javorka K; Tomori Z Physiol Bohemoslov; 1972; 21(5):517-22. PubMed ID: 4266220 [No Abstract] [Full Text] [Related]
16. [Mechanisms of action of catecholamines and of the so-called alpha- and beta-lytic agents on the cardiovascular system: function of the arteriovenous anastomoses]. Laborit H Clin Ter; 1968 Sep; 46(5):405-17. PubMed ID: 5747192 [No Abstract] [Full Text] [Related]
17. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B. Wiśniewska RJ Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629 [TBL] [Abstract][Full Text] [Related]
18. [Chemical and pharmacological study of new derivatives of noradrenaline]. Régnier G; Canevari R; Laubie M; Le Douarec JC Arzneimittelforschung; 1969 Oct; 19(10):1698-702. PubMed ID: 5395370 [No Abstract] [Full Text] [Related]
19. [Pharmacology of some derivatives of indole and benzofuran]. Il'iuchenok TIu; Frigidiva LM; Maksimenko AA; Trofimov FA Farmakol Toksikol; 1970; 33(5):576-81. PubMed ID: 5493217 [No Abstract] [Full Text] [Related]
20. Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999). Aramendía P; Kaumann AJ J Pharmacol Exp Ther; 1967 Feb; 155(2):259-66. PubMed ID: 6025517 [No Abstract] [Full Text] [Related] [Next] [New Search]